These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 6995041)

  • 41. Haemodynamic effects of ketanserin in the treatment of hypertension following CABG: a double-blind, placebo-controlled study.
    Vandenbroucke G; Foubert L; Evenepoel MC
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):3. PubMed ID: 2520966
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of beta-adrenergic blockade (propranolol) on left ventricular hemodynamics and the electrocardiogram during exercise-induced angina pectoris.
    Dwyer EM; Wiener L; Cox JW
    Circulation; 1968 Aug; 38(2):250-60. PubMed ID: 5666841
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of oxprenolol and propranolol on systolic time intervals.
    van Herick R; Aronow WS
    Clin Pharmacol Ther; 1978 Dec; 24(6):678-82. PubMed ID: 361333
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute and long-term haemodynamic effects of propranolol and indenolol in hypertension.
    Malacco E; Mailland F; Bosisio E; Meroni R; Dagani R; Renesto E; Bevilacqua M
    Eur J Clin Pharmacol; 1986; 30(2):157-60. PubMed ID: 3709639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Changes induced by acute and prolonged administration of propranolol in systemic hemodynamics in hypertensive patients].
    Branzi A; Sanguinetti M; Ambrosioni E; Magnani B
    Boll Soc Ital Cardiol; 1970; 15(6):627-33. PubMed ID: 5517658
    [No Abstract]   [Full Text] [Related]  

  • 46. Propranolol and renal hemodynamics at rest and during exercise.
    Malini PL; Strocchi E; Ambrosioni E
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):611-4. PubMed ID: 6668099
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemodynamic and plasma renin effects of propranolol in essential hypertension.
    Mookherjee S; Eich RH; Obeid AI; Smulyan H
    Arch Intern Med; 1977 Mar; 137(3):290-5. PubMed ID: 843147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of beta-adrenergic blockade during exercise in hypertensive and ischaemic heart-disease.
    Shinebourne E; Fleming J; Hamer J
    Lancet; 1967 Dec; 2(7528):1217-20. PubMed ID: 4168693
    [No Abstract]   [Full Text] [Related]  

  • 49. [Mechanism of the antihypertensive action of propranolol].
    Magnani B; Ambrosioni E; Branzi A; Maresta A; Picchio F; Russo F; Sanguinetti M
    Minerva Cardioangiol; 1973 Apr; 21(4):284-97. PubMed ID: 4710125
    [No Abstract]   [Full Text] [Related]  

  • 50. [Studies on the antihypertensive effect of propranolol and oxprenolol in man].
    Gilfrich HJ; Nicolescu RF; Rahn KH; Willems D
    Verh Dtsch Ges Inn Med; 1971; 77():934-7. PubMed ID: 5156090
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effects of propranolol on central hemodynamics in hypertensive patients at rest and during stress].
    Kästner C; Zott HJ; Wallrabe D
    Z Gesamte Inn Med; 1989 Aug; 44(15):442-5. PubMed ID: 2815888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Propranolol antagonism of phenylpropanolamine-induced hypertension.
    Pentel PR; Asinger RW; Benowitz NL
    Clin Pharmacol Ther; 1985 May; 37(5):488-94. PubMed ID: 3987172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The comparative hemodynamic effects of propranolol in chronically instrumented puppies and adult dogs.
    Driscoll DJ; Fukushige J; Lewis RM; Hartley CJ; Entman MJ
    Biol Neonate; 1982; 41(1-2):8-15. PubMed ID: 7066441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of indoramin and propranolol on cardiovascular response to cold in hypertensive patients.
    Velasco M; Urbina-Quintana A; Andrews-Figueroa P; Nieves D; Hernández E; Guevara-Casado J; Hernández-Pieretti O
    Clin Pharmacol Ther; 1982 Jul; 32(1):7-11. PubMed ID: 7083732
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of propranolol on myocardial perfusion images and exercise ejection fraction in men with coronary artery disease.
    Rainwater J; Steele P; Kirch D; LeFree M; Jensen D; Vogel R
    Circulation; 1982 Jan; 65(1):77-81. PubMed ID: 7053291
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
    Gibson DG
    Drugs; 1974; 7(1):8-38. PubMed ID: 4151693
    [No Abstract]   [Full Text] [Related]  

  • 57. Neurogenic maintenance of peripheral resistance in borderline hypertension.
    Julius S; Esler M; Randall OS; Ellis C
    Acta Physiol Lat Am; 1974; 24(5):425-31. PubMed ID: 4467668
    [No Abstract]   [Full Text] [Related]  

  • 58. Double blind cross-over study of the inotropic influence of Tiprenolol (DU21445) and propranolol in patients with ischaemic heart disease.
    Yan V; Sloman G
    Aust N Z J Med; 1973 Oct; 3(5):467-73. PubMed ID: 4149632
    [No Abstract]   [Full Text] [Related]  

  • 59. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K; Kubota M; Odashiro M; Yasuda K; Goto Y
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract]   [Full Text] [Related]  

  • 60. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
    Ravid M; Lang R; Jutrin I
    Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.